Biotech · Private company

Medarex

Track this companyFree. Adds Medarex to your Dealase workspace and tells you when its record changes.

Clinical trials40 recruiting or active

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Clinical trials4

Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV MelanomaPHASE1 · COMPLETED · started Aug 13, 2010ClinicalTrials.gov NCT01176474 · fetched Nov 12, 2026
Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558PHASE1 · COMPLETED · started Aug 4, 2010ClinicalTrials.gov NCT01176461 · fetched Nov 12, 2026
Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant MelanomaPHASE1 · COMPLETED · started Dec 14, 2009ClinicalTrials.gov NCT01024231 · fetched Nov 12, 2026
A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial SarcomaPHASE2 · TERMINATED · started Jun 8, 2005ClinicalTrials.gov NCT00140855 · fetched Nov 12, 2026